In addition, Avpr1a genotype and/or expression may represent a potential biomarker for VH susceptibility with implications for the etiology of IBS and other DGBI conditions as well as for novel therapeutic interventions targeting this specific underlying mechanism. This evidence concerns the gene AVPR1A and irritable bowel syndrome.